全文获取类型
收费全文 | 5051篇 |
免费 | 232篇 |
国内免费 | 321篇 |
专业分类
电工技术 | 93篇 |
综合类 | 220篇 |
化学工业 | 2093篇 |
金属工艺 | 835篇 |
机械仪表 | 28篇 |
建筑科学 | 93篇 |
矿业工程 | 128篇 |
能源动力 | 45篇 |
轻工业 | 642篇 |
水利工程 | 10篇 |
石油天然气 | 864篇 |
武器工业 | 16篇 |
无线电 | 30篇 |
一般工业技术 | 296篇 |
冶金工业 | 143篇 |
原子能技术 | 8篇 |
自动化技术 | 60篇 |
出版年
2024年 | 17篇 |
2023年 | 62篇 |
2022年 | 269篇 |
2021年 | 290篇 |
2020年 | 142篇 |
2019年 | 119篇 |
2018年 | 113篇 |
2017年 | 162篇 |
2016年 | 180篇 |
2015年 | 155篇 |
2014年 | 241篇 |
2013年 | 257篇 |
2012年 | 378篇 |
2011年 | 338篇 |
2010年 | 236篇 |
2009年 | 276篇 |
2008年 | 198篇 |
2007年 | 298篇 |
2006年 | 277篇 |
2005年 | 242篇 |
2004年 | 221篇 |
2003年 | 187篇 |
2002年 | 172篇 |
2001年 | 152篇 |
2000年 | 123篇 |
1999年 | 99篇 |
1998年 | 72篇 |
1997年 | 72篇 |
1996年 | 52篇 |
1995年 | 42篇 |
1994年 | 35篇 |
1993年 | 29篇 |
1992年 | 27篇 |
1991年 | 15篇 |
1990年 | 15篇 |
1989年 | 8篇 |
1988年 | 9篇 |
1987年 | 6篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 4篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有5604条查询结果,搜索用时 18 毫秒
21.
分析了我厂两碱法原卤净化后,加热管内壁结碳酸钙垢的原因,探讨了我厂采取加盐酸、加阻垢剂、用超声波阻垢器的方法,以及对加热管内碳酸钙垢防治的情况和存在的问题. 相似文献
22.
Conventional cancer therapies, the second leading cause of death worldwide, result in serious side effects and, at best, merely extend the patient''s lifespan by a few years. Searching for effective prevention is of high priority in both basic and clinical sciences. In recent decades natural products have been considered to be an important source of cancer chemopreventive agents. Red wine polyphenols, which consisted of various powerful antioxidants such as flavonoids and stilbenes, have been implicated in cancer prevention and that promote human health without recognizable side effects. Since resveratrol, a major component of red wine polyphenols, has been studied and reviewed extensively for its chemopreventive activity to interfere with the multi-stage carcinogenesis, this review focuses on recent progress in studies on cancer chemopreventive activities of red wine polyphenol extracts and fractions as well as other red wine polyphenols, like procyanidin B5 analogues and myricetin. 相似文献
23.
防霉建筑涂料的研究与施工使用 总被引:1,自引:1,他引:0
针对国内外防霉建筑涂料存在的问题,研制开发了以合成树脂为主要成膜物质,加入环保性杀菌防霉剂及具有防腐霉的功能性颜填料,再配以树脂固化剂等成分配制而成的高性能防霉建筑涂料,并指出该涂料防霉效果良好。 相似文献
24.
载银无机抗菌剂变色抑制剂研发现状 总被引:31,自引:0,他引:31
介绍了载银无机抗菌剂变色抑制剂如甲基苯并三唑、天然水滑石和合成水滑石等的研发现状 相似文献
25.
Inhibition of the major human drug-metabolizing cytochrome P450 3A4 (CYP3A4) by pharmaceuticals and other xenobiotics could lead to toxicity, drug–drug interactions and other adverse effects, as well as pharmacoenhancement. Despite serious clinical implications, the structural basis and attributes required for the potent inhibition of CYP3A4 remain to be established. We utilized a rational inhibitor design to investigate the structure–activity relationships in the analogues of ritonavir, the most potent CYP3A4 inhibitor in clinical use. This study elucidated the optimal length of the head-group spacer using eleven (series V) analogues with the R1/R2 side-groups as phenyls or R1–phenyl/R2–indole/naphthalene in various stereo configurations. Spectral, functional and structural characterization of the inhibitory complexes showed that a one-atom head-group linker elongation, from pyridyl–ethyl to pyridyl–propyl, was beneficial and markedly improved Ks, IC50 and thermostability of CYP3A4. In contrast, a two-atom linker extension led to a multi-fold decrease in the binding and inhibitory strength, possibly due to spatial and/or conformational constraints. The lead compound, 3h, was among the best inhibitors designed so far and overall, the strongest binder (Ks and IC50 of 0.007 and 0.090 µM, respectively). 3h was the fourth structurally simpler inhibitor superior to ritonavir, which further demonstrates the power of our approach. 相似文献
26.
Amir Mohammadzadeh Pter P. Lakatos Mihly Balogh Ferenc Zdor Dvid rpd Kardi Zoltn S. Zdori Kornl Kirly Anna Rita Galambos Szilvia Barsi Pl Riba Sndor Benyhe Lszl Kles Tams Tbi va Szk Laszlo G. Harsing Jr. Mahmoud Al-Khrasani 《International journal of molecular sciences》2021,22(5)
The limited effect of current medications on neuropathic pain (NP) has initiated large efforts to develop effective treatments. Animal studies showed that glycine transporter (GlyT) inhibitors are promising analgesics in NP, though concerns regarding adverse effects were raised. We aimed to study NFPS and Org-25543, GlyT-1 and GlyT-2 inhibitors, respectively and their combination in rat mononeuropathic pain evoked by partial sciatic nerve ligation. Cerebrospinal fluid (CSF) glycine content was also determined by capillary electrophoresis. Subcutaneous (s.c.) 4 mg/kg NFPS or Org-25543 showed analgesia following acute administration (30–60 min). Small doses of each compound failed to produce antiallodynia up to 180 min after the acute administration. However, NFPS (1 mg/kg) produced antiallodynia after four days of treatment. Co-treatment with subanalgesic doses of NFPS (1 mg/kg) and Org-25543 (2 mg/kg) produced analgesia at 60 min and thereafter meanwhile increased significantly the CSF glycine content. This combination alleviated NP without affecting motor function. Test compounds failed to activate G-proteins in spinal cord. To the best of our knowledge for the first time we demonstrated augmented analgesia by combining GlyT-1 and 2 inhibitors. Increased CSF glycine content supports involvement of glycinergic system. Combining selective GlyT inhibitors or developing non-selective GlyT inhibitors might have therapeutic value in NP. 相似文献
27.
Zhen Zeng Hui Yi Chew Jazmina G. Cruz Graham R. Leggatt James W. Wells 《International journal of molecular sciences》2021,22(6)
T cells play a key role in tumour surveillance, both identifying and eliminating transformed cells. However, as tumours become established they form their own suppressive microenvironments capable of shutting down T cell function, and allowing tumours to persist and grow. To further understand the tumour microenvironment, including the interplay between different immune cells and their role in anti-tumour immune responses, a number of studies from mouse models to clinical trials have been performed. In this review, we examine mechanisms utilized by tumour cells to reduce their visibility to CD8+ Cytotoxic T lymphocytes (CTL), as well as therapeutic strategies trialled to overcome these tumour-evasion mechanisms. Next, we summarize recent advances in approaches to enhance CAR T cell activity and persistence over the past 10 years, including bispecific CAR T cell design and early evidence of efficacy. Lastly, we examine mechanisms of T cell infiltration and tumour regression, and discuss the strengths and weaknesses of different strategies to investigate T cell function in murine tumour models. 相似文献
28.
Non-small-cell lung cancer (NSCLC) with Kirsten rat sarcoma (KRAS) mutations has notoriously challenged oncologists and researchers for three notable reasons: (1) the historical assumption that KRAS is “undruggable”, (2) the disease heterogeneity and (3) the shaping of the tumor microenvironment by KRAS downstream effector functions. Better insights into KRAS structural biochemistry allowed researchers to develop direct KRAS(G12C) inhibitors, which have shown early signs of clinical activity in NSCLC patients and have recently led to an FDA breakthrough designation for AMG-510. Following the approval of immune checkpoint inhibitors for PDL1-positive NSCLC, this could fuel yet another major paradigm shift in the treatment of advanced lung cancer. Here, we review advances in our understanding of the biology of direct KRAS inhibition and project future opportunities and challenges of dual KRAS and immune checkpoint inhibition. This strategy is supported by preclinical models which show that KRAS(G12C) inhibitors can turn some immunologically “cold” tumors into “hot” ones and therefore could benefit patients whose tumors harbor subtype-defining STK11/LKB1 co-mutations. Forty years after the discovery of KRAS as a transforming oncogene, we are on the verge of approval of the first KRAS-targeted drug combinations, thus therapeutically unifying Paul Ehrlich’s century-old “magic bullet” vision with Rudolf Virchow’s cancer inflammation theory. 相似文献
29.
Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles
Vanesa Nozal Elisa Rojas-Prats Ins Maestro Carmen Gil Daniel I. Perez Ana Martinez 《International journal of molecular sciences》2021,22(6)
Phosphodiesterase 7 (PDE7) is an enzyme responsible for the degradation of cyclic adenosine monophosphate (cAMP), an important cellular messenger. PDE7’s role in neurotransmission, expression profile in the brain and the druggability of other phosphodiesterases have motivated the search for potent inhibitors to treat neurodegenerative and inflammatory diseases. Different heterocyclic compounds have been described over the years; among them, phenyl-2-thioxo-(1H)-quinazolin-4-one, called S14, has shown very promising results in different in vitro and in vivo studies. Recently, polymeric nanoparticles have been used as new formulations to target specific organs and produce controlled release of certain drugs. In this work, we describe poly(lactic-co-glycolic acid) (PLGA)-based polymeric nanoparticles loaded with S14. Their preparation, optimization, characterization and in vivo drug release profile are here presented as an effort to improve pharmacokinetic properties of this interesting PDE7 inhibitor. 相似文献
30.
在减缓金属腐蚀的研究中,为了缓解在酸性溶液、碱性溶液以及大气、土壤等介质中金属腐蚀较为严重的问题,对咪唑啉类缓蚀剂进行了工艺条件优化.采用静态失重法研究了碳钢在加入了缓蚀剂的盐酸溶液中的缓蚀性能.在最佳合成条件下苯甲酸与二乙烯三胺最佳摩尔比为1∶1.3,催化剂质量分数为1.2%,环化时间为1 h,咪唑啉中间体与氯化苄的最佳摩尔比为1∶1.1,季铵化反应时间为1 h,季铵化反应温度为70 ℃,缓蚀剂的最佳质量分数为1%,最终缓蚀率可以达到99.37%. 相似文献